# 8. Dosing Guidelines

[← Previous: Adverse Effects](07-adverse-effects.md) | [Back to Main](../README.md) | [Next: Monitoring →](09-monitoring.md)

---

## 8.1 Adult Dosing Reference

| ASM | Starting Dose | Titration | Target/Maintenance | Maximum |
|-----|---------------|-----------|-------------------|---------|
| **Levetiracetam** | 250-500 mg BID | ↑500 mg/day every 2 weeks | 1000-1500 mg BID | 3000 mg/day |
| **Lamotrigine** (no VPA) | 25 mg daily | Week 1-2: 25 mg/day; Week 3-4: 50 mg/day; ↑50 mg every 1-2 weeks | 100-200 mg BID | 400-600 mg/day |
| **Lamotrigine** (with VPA) | 25 mg every other day | Week 1-2: 25 mg QOD; Week 3-4: 25 mg/day; ↑25-50 mg every 2 weeks | 50-100 mg BID | 200 mg/day |
| **Valproate** | 250 mg BID | ↑250 mg every 3-7 days | 500-1000 mg BID | 60 mg/kg/day |
| **Carbamazepine** | 100-200 mg BID | ↑200 mg/day weekly | 400-600 mg BID | 1600 mg/day |
| **Oxcarbazepine** | 300 mg BID | ↑300 mg/day weekly | 600-1200 mg BID | 2400 mg/day |
| **Eslicarbazepine** | 400 mg daily | ↑400 mg weekly | 800-1200 mg daily | 1600 mg/day |
| **Phenytoin** | 100 mg TID or 300 mg QHS | Adjust per levels | Per therapeutic level | Per level |
| **Lacosamide** | 50 mg BID | ↑50 mg BID weekly | 100-200 mg BID | 400 mg/day |
| **Topiramate** | 25 mg daily | ↑25-50 mg/day weekly | 100-200 mg BID | 400 mg/day |
| **Zonisamide** | 100 mg daily | ↑100 mg every 2 weeks | 200-400 mg daily | 600 mg/day |
| **Gabapentin** | 300 mg TID | ↑300 mg/day every 3-7 days | 300-600 mg TID | 3600 mg/day |
| **Pregabalin** | 50-75 mg BID | ↑150 mg/day weekly | 150-300 mg BID | 600 mg/day |
| **Perampanel** | 2 mg QHS | ↑2 mg every 2 weeks | 4-8 mg QHS | 12 mg/day |
| **Brivaracetam** | 25-50 mg BID | ↑25-50 mg BID weekly | 50-100 mg BID | 200 mg/day |
| **Clobazam** | 5 mg daily | ↑5 mg every 5-7 days | 10-20 mg BID | 40 mg/day |

---

## 8.2 Lamotrigine Titration Schedules

### Without Valproate or Enzyme Inducers

| Week | Daily Dose |
|------|------------|
| 1-2 | 25 mg once daily |
| 3-4 | 50 mg once daily |
| 5 | 100 mg (50 mg BID) |
| 6 | 150 mg (75 mg BID) |
| 7+ | 200 mg (100 mg BID) |

### With Valproate

| Week | Daily Dose |
|------|------------|
| 1-2 | 25 mg every other day |
| 3-4 | 25 mg once daily |
| 5-6 | 50 mg once daily |
| 7-8 | 100 mg (50 mg BID) |
| Target | 100-200 mg/day |

### With Enzyme Inducers (CBZ, PHT, PB)

| Week | Daily Dose |
|------|------------|
| 1-2 | 50 mg once daily |
| 3-4 | 100 mg (50 mg BID) |
| 5 | 200 mg (100 mg BID) |
| 6 | 300 mg (150 mg BID) |
| Target | 300-500 mg/day |

---

## 8.3 IV Loading Doses (Emergency/Inpatient)

| ASM | Loading Dose | Rate | Notes |
|-----|--------------|------|-------|
| **Levetiracetam** | 20-60 mg/kg | Over 15 min | Max 4500 mg |
| **Valproate** | 20-40 mg/kg | 3-6 mg/kg/min | Max 3000 mg |
| **Fosphenytoin** | 15-20 mg PE/kg | Max 150 mg PE/min | Cardiac monitoring |
| **Phenytoin** | 15-20 mg/kg | Max 50 mg/min | Cardiac monitoring |
| **Phenobarbital** | 15-20 mg/kg | 50-100 mg/min | Respiratory monitoring |
| **Lacosamide** | 200-400 mg | Over 15-30 min | PR interval monitoring |

---

## 8.4 Therapeutic Drug Monitoring

| ASM | Therapeutic Range | When to Monitor |
|-----|-------------------|-----------------|
| **Phenytoin** | 10-20 mcg/mL (total); 1-2 mcg/mL (free) | Baseline, after dose changes, drug interactions, pregnancy |
| **Carbamazepine** | 4-12 mcg/mL | After dose changes, suspected toxicity |
| **Valproate** | 50-100 mcg/mL | Baseline, after dose changes, suspected toxicity |
| **Phenobarbital** | 15-40 mcg/mL | After dose changes, suspected toxicity |
| **Lamotrigine** | 3-14 mcg/mL | Pregnancy (monthly), drug interactions |
| **Levetiracetam** | 12-46 mcg/mL | Adherence concerns, renal impairment |
| **Lacosamide** | 5-10 mcg/mL | Rarely needed |
| **Oxcarbazepine** (MHD) | 12-35 mcg/mL | Hyponatremia monitoring more important |

---

## 8.5 Renal Dosing Adjustments

| ASM | CrCl 30-60 | CrCl 15-30 | CrCl <15 / HD |
|-----|------------|------------|---------------|
| **Levetiracetam** | 50-75% dose | 50% dose | 50% dose; supplement after HD |
| **Gabapentin** | 50% dose | 25% dose | 100-300 mg/day; supplement after HD |
| **Pregabalin** | 50% dose | 25% dose | 25-75 mg/day; supplement after HD |
| **Topiramate** | 50% dose | 50% dose | 50% dose |
| **Lacosamide** | No change | No change | Max 300 mg/day |
| **Brivaracetam** | No change | No change | No change |
| **Eslicarbazepine** | No change | Max 800 mg/day | Max 600 mg/day |

---

## 8.6 Hepatic Dosing Adjustments

| ASM | Mild Impairment | Moderate Impairment | Severe Impairment |
|-----|-----------------|---------------------|-------------------|
| **Levetiracetam** | No change | No change | 50% dose (consider) |
| **Gabapentin** | No change | No change | No change |
| **Pregabalin** | No change | No change | No change |
| **Lacosamide** | No change | Max 300 mg/day | Max 300 mg/day |
| **Lamotrigine** | No change | 50% dose | 25% dose |
| **Carbamazepine** | Use with caution | Avoid | Avoid |
| **Eslicarbazepine** | No change | Use with caution | Avoid |
| **Valproate** | Avoid | Avoid | Contraindicated |

---

## 8.7 Conversion Between Formulations

### Phenytoin ↔ Fosphenytoin

```
Fosphenytoin dosed as Phenytoin Equivalents (PE)
1 mg PE fosphenytoin = 1 mg phenytoin
```

### Oral ↔ IV Conversion

| ASM | Conversion |
|-----|------------|
| Levetiracetam | 1:1 (oral = IV) |
| Valproate | 1:1 (oral = IV) |
| Lacosamide | 1:1 (oral = IV) |
| Phenytoin | 1:1 (oral = IV) |

### Extended-Release Conversions

| Conversion | Notes |
|------------|-------|
| Carbamazepine IR → XR | Same total daily dose; give XR BID |
| Oxcarbazepine → Eslicarbazepine | OXC 600 mg BID ≈ ESL 800 mg daily |
| Levetiracetam IR → XR | Same total daily dose; give XR daily |

---

[← Previous: Adverse Effects](07-adverse-effects.md) | [Back to Main](../README.md) | [Next: Monitoring →](09-monitoring.md)
